Back
BeiGene 10K Form
Buy
54
ONC
BeiGene
Last Price:
$256.07
Seasonality Move:
18.63%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ONC News And Ratings
See the #1 stock for the next 7 days that we like better than ONC
ONC Financial Statistics
Sales & Book Value
| Annual Sales: | $3.8B |
|---|---|
| Cash Flow: | $-17.3M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $31.28 |
| Price / Book: | 8.27 |
Profitability
| EPS (TTM): | -6.24000 |
|---|---|
| Net Income (TTM): | $-644.8M |
| Gross Margin: | $3.2B |
| Return on Equity: | -18.93% |
| Return on Assets: | -11.14% |
BeiGene Earnings Forecast
Key BeiGene Financial Ratios
-
The Gross Profit Margin over the past 10 years for ONC is 84.41%.
-
The Selling, General & Administrative Expenses for ONC have been equal to 48.06% of Gross Profit Margin.
-
The Research & Development expenses have been 51.26% of Revenue.
-
The Net Earning history of ONC is -16.92% of Total Revenues.
-
Per Share Earnings over the last 12 years have been positive in 4 years.
BeiGene Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ONC |
| Website: | beigene.com |
Debt
| Debt-to-Equity Ratio: | 0.31 |
|---|---|
| Current Ratio: | 1.8 |
| Quick Ratio: | 1.51 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 41.14 |